K
Kaio César Simiano Tavares
Researcher at University of Fortaleza
Publications - 51
Citations - 314
Kaio César Simiano Tavares is an academic researcher from University of Fortaleza. The author has contributed to research in topics: Trypanosoma evansi & Gene expression. The author has an hindex of 8, co-authored 48 publications receiving 259 citations. Previous affiliations of Kaio César Simiano Tavares include Universidade do Estado de Santa Catarina.
Papers
More filters
Journal ArticleDOI
The transgenic animal platform for biopharmaceutical production.
Luciana Relly Bertolini,Luciana Relly Bertolini,H. Meade,Cicera R. Lazzarotto,L. T. Martins,Kaio César Simiano Tavares,Marcelo Bertolini,Marcelo Bertolini,James D. Murray +8 more
TL;DR: The approval of two mammary gland-derived recombinant proteins for commercial and clinical use has boosted the interest for more efficient, safer and economic ways to generate transgenic founders to meet the increasing demand for biomedical proteins worldwide.
Journal ArticleDOI
Oleanolic acid promotes orofacial antinociception in adult zebrafish (Danio rerio) through TRPV1 receptors.
Isabel Cristina R. Soares,Sacha Aubrey Alves Rodrigues Santos,Regina Freitas Coelho,Yuri A. Alves,Antonio Eufrásio Vieira-Neto,Kaio César Simiano Tavares,Francisco Ernani Alves Magalhães,Adriana Rolim Campos +7 more
TL;DR: Results confirm the potential pharmacological relevance of oleanolic acid as an inhibitor of orofacial nociception mediated by TRPV1 and docking studies indicated that o Leanolic acid may interact with TRpV1.
Journal ArticleDOI
Susceptibility of Trypanosoma evansi to human blood and plasma in infected mice.
Mateus Anderson Otto,Aleksandro Schafer da Silva,Lucas T. Gressler,Matheus Hilliard Farret,Kaio César Simiano Tavares,Régis Adriel Zanette,Luiz Claudio Miletti,Silvia Gonzalez Monteiro +7 more
TL;DR: Investigation of the susceptibility of T. evansi isolates to therapy using human blood and plasma in experimentally infected mice found that four treatments increased animals longevity when compared to group A, and treatments were capable of curing 50% of mice of group B, 37.5% of group C, 38.5%" of group D and 25% of the animals from group E.
Journal ArticleDOI
Developmental Outcome and Related Abnormalities in Goats: Comparison Between Somatic Cell Nuclear Transfer- and In Vivo-Derived Concepti During Pregnancy Through Term
L. T. Martins,Saul Gaudencio Neto,Kaio César Simiano Tavares,Carlos Enrique Méndez Calderón,L. H. Aguiar,Cicera R. Lazzarotto,Felipe Ledur Ongaratto,V. H. V. Rodrigues,I. S. Carneiro,Rafael Rossetto,A. P. Almeida,César Carneiro Linhares Fernandes,Davide Rondina,Ana Christina de Oliveira Dias,Jocelei Maria Chies,Irina A. Polejaeva,José Luiz Rodrigues,Fabiana Forell,Luciana Relly Bertolini,Marcelo Bertolini +19 more
TL;DR: Overall, goat cloning showed losses and abnormality patterns similar to the AOS in cloned cattle and sheep, which have not been previously well recognized in goats.
Journal Article
A New Therapeutic Protocol for Dogs Infected with Trypanosoma evansi
Flávia Howes,Aleksandro S. Da Silva,Cristiane de Lima Athayde,Márcio Machado Costa,Marcos Matoso Burgo Corrêa,Kaio César Simiano Tavares,Luiz Claudio Miletti,Sonia Terezinha dos Anjos Lopes,Anne Santos do Amaral,Claudete Schmidt +9 more
TL;DR: A parasite infection caused by a flagellate protozoan known as Trypanosoma evansi, transmitted by hematophagous insects, is shown to cause trypanosomosis.